Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research

<p>Key concepts, examples, and potential solutions for misuses and pitfalls of <i>P</i> values.</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Ming Wang (8809334) (author)
Andere auteurs:	Qi Long (22677196) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Methods and Technology Epidemiology Biostatistics Computational Methods Methodology and Modeling
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
door: Jeffrey D. Mandell (14963909)
Gepubliceerd in: (2025)

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
door: Nina Rao (15321199)
Gepubliceerd in: (2025)

Supplemental Fig. 1 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
door: Noura J. Choudhury (15029759)
Gepubliceerd in: (2025)

Supplemental Fig. 2 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
door: Noura J. Choudhury (15029759)
Gepubliceerd in: (2025)

Supplemental Fig. 3 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
door: Noura J. Choudhury (15029759)
Gepubliceerd in: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
door: Hanyun Zhang (15386757)
Gepubliceerd in: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
door: Hanyun Zhang (15386757)
Gepubliceerd in: (2025)

Performance advantage of leading researchers compared to non-leading researchers (Mean values for leading researchers).
door: Gerhard Reichmann (17972544)
Gepubliceerd in: (2025)

Your PDF contains <b>multiple lecture PPTs</b> from the GIAN course on <i>Migration, Gender, Labour, and International Standards</i>. The content spans historical, sociological, legal, and policy-oriented dimensions of migration.
door: Ganesh Satarkar (22667600)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S2 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S3 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S4 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S5 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S6 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S7 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Figure S8 from Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
door: Alessio Cortellini (11023993)
Gepubliceerd in: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
door: Achal Patel (5853731)
Gepubliceerd in: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
door: Shuwei Li (16437116)
Gepubliceerd in: (2025)

Supplementary Table 19 from Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms
door: Pascal Belleau (14960153)
Gepubliceerd in: (2025)

Research attributes of leading vs. non-leading researchers: aggregate ranking (Category 2).
door: Gerhard Reichmann (17972544)
Gepubliceerd in: (2025)

The standard curves by the methods of SDM (<i>P </i> = 0.0036) and SSDM (<i>P</i> < 0.001).
door: Fei Chen (13690)
Gepubliceerd in: (2025)

Leading researchers: aggregate ranking 2 (Category 2).
door: Gerhard Reichmann (17972544)
Gepubliceerd in: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
door: Sami Belhadj (15052341)
Gepubliceerd in: (2025)

Leading researchers: aggregate ranking 1 (Categories 1 and 2).
door: Gerhard Reichmann (17972544)
Gepubliceerd in: (2025)

Leading researchers: individual rankings V1-V10.
door: Gerhard Reichmann (17972544)
Gepubliceerd in: (2025)

Cultivation of <i>Spirulina</i>(<i>Limnospira platensis</i>) using low cost media and its potential to address challenges posed by climate change in the semiarid regions of Southern Africa
door: Keletso Masisi (22675358)
Gepubliceerd in: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
door: Erwei Zeng (14958443)
Gepubliceerd in: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
door: Josephine K. Dermawan (17079555)
Gepubliceerd in: (2025)

The Items addressed in proposed strategies by the teams categorized in the PEN-3 domains.
door: Maria A. Afadapa (22683548)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_g082t769qq5d6tnr88eso4u7rf